Mogens Guldberg, general manager of Novo Nordisk Austria, the Danish global powerhouse focused on innovative diabetic treatments, provides a unique insight into the obstacles associated with launching innovative products in Austria as well as the revolution required in Austria’s diabetic approach. He also highlights how specifically Novo Nordisk assists in inciting a social difference and positively changing the lives of people with diabetes.
You have an impressive 19-year history at the company, what was your mission when you took up the country manager position at Novo Nordisk Austria?
"Novo Nordisk Austria endeavours to transfer to the people with diabetes our innovative treatments and in the meantime, support affected people with diabetes along their journey with this life changing condition."
